Bioregenx (BRGX) Current Assets (2021 - 2026)

Bioregenx's Current Assets history runs 6 years deep, the most recent figure standing at $190292.0 for Q1 2026.

• In Q1 2026, Current Assets fell 35.33% year-over-year to $190292.0; the TTM figure through Mar 2026 stood at $190292.0 (down 35.33% YoY), while the FY2025 annual figure was $251265.0, down 18.37% from the prior year.
• Current Assets was $190292.0 for Q1 2026 at Bioregenx, down from $251265.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $652664.0 in Q4 2023 to a low of $676.0 in Q4 2022.
• Historically, Current Assets has averaged $283585.1 across 5 years, with a median of $283708.5 in 2025.
• The sharpest annual moves came in 2022 and 2023: Current Assets plunged 97.22% in 2022, then soared 96447.93% in 2023.
• A 5-year view of Current Assets shows it stood at $676.0 in 2022, then jumped by 96447.93% to $652664.0 in 2023, then slumped by 52.84% to $307796.0 in 2024, then dropped by 18.37% to $251265.0 in 2025, then retreated by 24.27% to $190292.0 in 2026.
• The last three Current Assets figures came in at $190292.0 (Q1 2026), $251265.0 (Q4 2025), and $273156.0 (Q3 2025), per Business Quant data.